Matches in SemOpenAlex for { <https://semopenalex.org/work/W2977321077> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2977321077 endingPage "S44" @default.
- W2977321077 startingPage "S43" @default.
- W2977321077 abstract "Purpose: TZP-101, a ghrelin agonist, has been shown to accelerate gastric emptying (GE) in diabetic patients with gastroparesis (GP) by 4-h scintigraphy. The goal was to evaluate TZP-101 effects on symptoms in diabetic patients with GP. Methods: USA and European Centers participated in a randomized, placebo controlled study of 76 diabetic patients with GP (presence of symptoms & demonstration of delayed GE). For 4 days, patients received a 30 min IV infusion of one of six TZP-101 doses (range 20-600μg/kg) or placebo (57 received TZP-101; 19 received placebo); elective hospitalization; efficacy was evaluated by: Gastroparesis Cardinal Symptom Index (GCSI) - daily; meal-related Gastroparesis Symptom Assessment (GSA) - daily; and Clinician Rated Symptom Assessment (CRSA) - end of treatment; gastric emptying; regular battery of safety assessment tests; 30-day follow up for efficacy and safety. Results: TZP-101 induced gradual symptom improvement over 4 days while placebo showed no change or gradual deterioration (vomiting & early satiety shown). Of all doses, the 80μg/kg dose was the most effective. At the end of dosing (80 μg/kg over placebo) the following symptoms improved significantly/trend toward significance: GCSI: vomiting (p=0.006), loss of appetite (p=0.034), early satiety (p=0.087); sustained effect on vomiting for 30 days (p=0.03); GSA (shown): postprandial fullness (p=0.007); CRSA: early satiety (p=0.089), abdominal distension (p=0.053), bloating (p=0.082). During the 30-day follow-up period, 3% of patients on TZP-101 vs. 10% on placebo were hospitalized due to GP. When GE was reassessed on the day after the 4th infusion, TZP-101 accelerated GE rate by 25% (vs. 8% on placebo); TZP-101 was safe and well tolerated for all doses studied. Conclusion: TZP-101, given IV for 4 consecutive days in diabetic GP patients, had a significant impact on vomiting, loss of appetite and fullness/early satiety as well as GE. Further TZP-101 evaluation in diabetic GP patients is anticipated since the results suggest a number of potential clinical benefits including improved glucose control and better nutrition. This research was supported by an industry grant from Tranzyme, Inc.Figure: Symptoms on day 4 - GSA." @default.
- W2977321077 created "2019-10-10" @default.
- W2977321077 creator A5000459214 @default.
- W2977321077 creator A5005028574 @default.
- W2977321077 creator A5006433297 @default.
- W2977321077 creator A5011073694 @default.
- W2977321077 creator A5027592480 @default.
- W2977321077 creator A5030570962 @default.
- W2977321077 creator A5031745487 @default.
- W2977321077 creator A5039354063 @default.
- W2977321077 creator A5065307928 @default.
- W2977321077 creator A5065392328 @default.
- W2977321077 creator A5073513342 @default.
- W2977321077 creator A5075469483 @default.
- W2977321077 date "2009-10-01" @default.
- W2977321077 modified "2023-10-01" @default.
- W2977321077 title "Ghrelin Agonist TZP-101 Improves Symptoms and Gastric Emptying in Diabetic Patients with Gastroparesis" @default.
- W2977321077 doi "https://doi.org/10.14309/00000434-200910003-00109" @default.
- W2977321077 hasPublicationYear "2009" @default.
- W2977321077 type Work @default.
- W2977321077 sameAs 2977321077 @default.
- W2977321077 citedByCount "1" @default.
- W2977321077 crossrefType "journal-article" @default.
- W2977321077 hasAuthorship W2977321077A5000459214 @default.
- W2977321077 hasAuthorship W2977321077A5005028574 @default.
- W2977321077 hasAuthorship W2977321077A5006433297 @default.
- W2977321077 hasAuthorship W2977321077A5011073694 @default.
- W2977321077 hasAuthorship W2977321077A5027592480 @default.
- W2977321077 hasAuthorship W2977321077A5030570962 @default.
- W2977321077 hasAuthorship W2977321077A5031745487 @default.
- W2977321077 hasAuthorship W2977321077A5039354063 @default.
- W2977321077 hasAuthorship W2977321077A5065307928 @default.
- W2977321077 hasAuthorship W2977321077A5065392328 @default.
- W2977321077 hasAuthorship W2977321077A5073513342 @default.
- W2977321077 hasAuthorship W2977321077A5075469483 @default.
- W2977321077 hasConcept C126322002 @default.
- W2977321077 hasConcept C142724271 @default.
- W2977321077 hasConcept C204787440 @default.
- W2977321077 hasConcept C27081682 @default.
- W2977321077 hasConcept C2776956441 @default.
- W2977321077 hasConcept C2777247143 @default.
- W2977321077 hasConcept C2778199505 @default.
- W2977321077 hasConcept C2778769438 @default.
- W2977321077 hasConcept C2779306644 @default.
- W2977321077 hasConcept C2779357093 @default.
- W2977321077 hasConcept C2779422922 @default.
- W2977321077 hasConcept C2780580376 @default.
- W2977321077 hasConcept C2780852908 @default.
- W2977321077 hasConcept C3020479747 @default.
- W2977321077 hasConcept C42219234 @default.
- W2977321077 hasConcept C71315377 @default.
- W2977321077 hasConcept C71924100 @default.
- W2977321077 hasConcept C75908981 @default.
- W2977321077 hasConcept C90924648 @default.
- W2977321077 hasConceptScore W2977321077C126322002 @default.
- W2977321077 hasConceptScore W2977321077C142724271 @default.
- W2977321077 hasConceptScore W2977321077C204787440 @default.
- W2977321077 hasConceptScore W2977321077C27081682 @default.
- W2977321077 hasConceptScore W2977321077C2776956441 @default.
- W2977321077 hasConceptScore W2977321077C2777247143 @default.
- W2977321077 hasConceptScore W2977321077C2778199505 @default.
- W2977321077 hasConceptScore W2977321077C2778769438 @default.
- W2977321077 hasConceptScore W2977321077C2779306644 @default.
- W2977321077 hasConceptScore W2977321077C2779357093 @default.
- W2977321077 hasConceptScore W2977321077C2779422922 @default.
- W2977321077 hasConceptScore W2977321077C2780580376 @default.
- W2977321077 hasConceptScore W2977321077C2780852908 @default.
- W2977321077 hasConceptScore W2977321077C3020479747 @default.
- W2977321077 hasConceptScore W2977321077C42219234 @default.
- W2977321077 hasConceptScore W2977321077C71315377 @default.
- W2977321077 hasConceptScore W2977321077C71924100 @default.
- W2977321077 hasConceptScore W2977321077C75908981 @default.
- W2977321077 hasConceptScore W2977321077C90924648 @default.
- W2977321077 hasLocation W29773210771 @default.
- W2977321077 hasOpenAccess W2977321077 @default.
- W2977321077 hasPrimaryLocation W29773210771 @default.
- W2977321077 hasRelatedWork W1769678725 @default.
- W2977321077 hasRelatedWork W1980123723 @default.
- W2977321077 hasRelatedWork W1992611765 @default.
- W2977321077 hasRelatedWork W2093100602 @default.
- W2977321077 hasRelatedWork W2119052802 @default.
- W2977321077 hasRelatedWork W2581173707 @default.
- W2977321077 hasRelatedWork W3028403238 @default.
- W2977321077 hasRelatedWork W3089968759 @default.
- W2977321077 hasRelatedWork W3145249567 @default.
- W2977321077 hasRelatedWork W4239697823 @default.
- W2977321077 hasVolume "104" @default.
- W2977321077 isParatext "false" @default.
- W2977321077 isRetracted "false" @default.
- W2977321077 magId "2977321077" @default.
- W2977321077 workType "article" @default.